English

PHARMACOPEIA INC

EDGAR

Quarterly report (10-Q) · filed 2008-11-06

21 filing records in this dataset, filed from 2004-06-02 to 2008-11-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.92 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 5922000 USD Source

Operating margin

-222.09%

2008-09-30 · %

Exact inputs and evidence

Operating Income: -13152000 USD Source
Revenue: 5922000 USD Source

Operating cash flow

-10.5 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -35463000 USD Source
Operating Cash Flow: -25008000 USD Source

Free cash flow

-10.7 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -35463000 USD Source
Operating Cash Flow: -25008000 USD Source
Capital Expenditure: 1657000 USD Source
Capital Expenditure: 1434000 USD Source

Cash and cash equivalents: 33.4 million USD 2008-09-30 Source
Exact value

33436000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

23 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Revenue: 21406000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 16395000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 6204000 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 5882000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 5922000 USD · 2008-07-01 – 2008-09-30 Source

Net income

-57.4 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Net income: -47860000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -28605000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -11718000 USD · 2008-01-01 – 2008-03-31 Source
Net income: -15599000 USD · 2008-04-01 – 2008-06-30 Source
Net income: -10817000 USD · 2008-07-01 – 2008-09-30 Source

Operating cash flow

-45.1 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: -11137000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -1470000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -8822000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -25008000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -8822000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -35463000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -25008000 USD · 2008-01-01 – 2008-06-30 Source

Capital expenditure

4.22 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Capital expenditure: 5908000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 3349000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 840000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 1434000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 840000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 1657000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 1434000 USD · 2008-01-01 – 2008-06-30 Source

Free cash flow

-49.3 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: -11137000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -1470000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -8822000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -25008000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -8822000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -35463000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -25008000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 5908000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 3349000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 840000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 1434000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 840000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 1657000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 1434000 USD · 2008-01-01 – 2008-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-06.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2007-12-31
Operating income: 3 of 11 periods available· newest 2007-12-31
Net income: 6 of 11 periods available· newest 2007-12-31
Operating cash flow: 6 of 11 periods available· newest 2007-12-31
Capital expenditure: 6 of 11 periods available· newest 2007-12-31
Total assets: 5 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 2007-12-31
Current liabilities: 5 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+26.4%

Prior period

USD 16.94 million

2006-01-01 – 2006-12-31
Current period

USD 21.41 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

21406000 − 16936000 = 4470000 USD

16936000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
21406000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Year-over-year change in Revenue: 4470000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 21406000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#5416 Input fundies:Revenue: 16936000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#5416
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 20.1 million

Prior period

−USD 27.76 million

2006-01-01 – 2006-12-31
Current period

−USD 47.86 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-47860000 − -27764000 = -20096000 USD

-27764000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-47860000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Year-over-year change in Net income: -20096000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -47860000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#6868 Input fundies:NetIncome: -27764000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#6868
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.19 million

Prior period

−USD 5.95 million

2006-01-01 – 2006-12-31
Current period

−USD 11.14 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-11137000 − -5946000 = -5191000 USD

-5946000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-11137000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Year-over-year change in Operating cash flow: -5191000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -11137000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 Input fundies:OperatingCashFlow: -5946000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+120.8%

Prior period

USD 2.68 million

2006-01-01 – 2006-12-31
Current period

USD 5.91 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

5908000 − 2676000 = 3232000 USD

2676000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
5908000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Year-over-year change in Capital expenditure: 3232000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5908000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 Input fundies:CapitalExpenditure: 2676000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 21.41 million 100% of revenue
Operating costs Derived USD 74 million 346% of revenue
Operating income −USD 52.59 million −246% of revenue
Tax, interest and other Derived −USD 4.73 million −22% of revenue
Net income −USD 47.86 million −224% of revenue

Cash

Operating cash flow −USD 11.14 million −52% of revenue
Capital expenditure USD 5.91 million 28% of revenue
Free cash flow Derived −USD 17.05 million −80% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Operating loss: operating costs were 191% of revenue.
2006 Operating loss: operating costs were 277% of revenue.
2007 Operating loss: operating costs were 346% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	29304000	Unavailable	Unavailable	Unavailable	-2142000	-1112000 Derived	Source 2002-01-01 – 2002-12-31: 29304000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -2142000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -263000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 849000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	29503000	Unavailable	Unavailable	Unavailable	-2848000	-8943000 Derived	Source 2003-01-01 – 2003-12-31: 29503000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2848000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -4780000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 4163000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	24359000	Unavailable	Unavailable	Unavailable	-17420000	-16143000 Derived	Source 2004-01-01 – 2004-12-31: 24359000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -17420000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -9006000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 7137000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	20403000	38895000 Derived	-18492000	-1354000 Derived	-17138000	-18501000 Derived	Source 2005-01-01 – 2005-12-31: 20403000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -18492000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -17138000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -17441000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 1060000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	16936000	46923000 Derived	-29987000	-2223000 Derived	-27764000	-8622000 Derived	Source 2006-01-01 – 2006-12-31: 16936000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -29987000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -27764000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -5946000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 2676000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	21406000	73999000 Derived	-52593000	-4733000 Derived	-47860000	-17045000 Derived	Source 2007-01-01 – 2007-12-31: 21406000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -52593000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -47860000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -11137000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 5908000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 21.4M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	29304000	Revenue: 29304000 Open source
20032003-12-31	Revenue	29503000	Revenue: 29503000 Open source
20042004-12-31	Revenue	24359000	Revenue: 24359000 Open source
20052005-12-31	Revenue	20403000	Revenue: 20403000 Open source
20062006-12-31	Revenue	16936000	Revenue: 16936000 Open source
20072007-12-31	Revenue	21406000	Revenue: 21406000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

26.4% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 29304000 Open source
20032003-12-31	Year over year	0.7%	Revenue: 29503000 Open source Revenue: 29304000 Open source
20042004-12-31	Year over year	-17.4%	Revenue: 24359000 Open source Revenue: 29503000 Open source
20052005-12-31	Year over year	-16.2%	Revenue: 20403000 Open source Revenue: 24359000 Open source
20062006-12-31	Year over year	-17%	Revenue: 16936000 Open source Revenue: 20403000 Open source
20072007-12-31	Year over year	26.4%	Revenue: 21406000 Open source Revenue: 16936000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -245.7% 2007

Net margin -223.6% 2007

Free cash flow margin -79.6% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Operating margin	Not reported	Revenue: 29304000 Open source
2003-12-31	Operating margin	Not reported	Revenue: 29503000 Open source
2004-12-31	Operating margin	Not reported	Revenue: 24359000 Open source
20052005-12-31	Operating margin	-90.6%	Operating Income: -18492000 Open source Revenue: 20403000 Open source
20062006-12-31	Operating margin	-177.1%	Operating Income: -29987000 Open source Revenue: 16936000 Open source
20072007-12-31	Operating margin	-245.7%	Operating Income: -52593000 Open source Revenue: 21406000 Open source
20022002-12-31	Net margin	-7.3%	Net Income: -2142000 Open source Revenue: 29304000 Open source
20032003-12-31	Net margin	-9.7%	Net Income: -2848000 Open source Revenue: 29503000 Open source
20042004-12-31	Net margin	-71.5%	Net Income: -17420000 Open source Revenue: 24359000 Open source
20052005-12-31	Net margin	-84%	Net Income: -17138000 Open source Revenue: 20403000 Open source
20062006-12-31	Net margin	-163.9%	Net Income: -27764000 Open source Revenue: 16936000 Open source
20072007-12-31	Net margin	-223.6%	Net Income: -47860000 Open source Revenue: 21406000 Open source
20022002-12-31	Free cash flow margin	-3.8%	Revenue: 29304000 Open source Operating Cash Flow: -263000 Open source Capital Expenditure: 849000 Open source
20032003-12-31	Free cash flow margin	-30.3%	Revenue: 29503000 Open source Operating Cash Flow: -4780000 Open source Capital Expenditure: 4163000 Open source
20042004-12-31	Free cash flow margin	-66.3%	Revenue: 24359000 Open source Operating Cash Flow: -9006000 Open source Capital Expenditure: 7137000 Open source
20052005-12-31	Free cash flow margin	-90.7%	Revenue: 20403000 Open source Operating Cash Flow: -17441000 Open source Capital Expenditure: 1060000 Open source
20062006-12-31	Free cash flow margin	-50.9%	Revenue: 16936000 Open source Operating Cash Flow: -5946000 Open source Capital Expenditure: 2676000 Open source
20072007-12-31	Free cash flow margin	-79.6%	Revenue: 21406000 Open source Operating Cash Flow: -11137000 Open source Capital Expenditure: 5908000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -11.1M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-263000	Operating Cash Flow: -263000 Open source
20032003-12-31	Operating cash flow	-4780000	Operating Cash Flow: -4780000 Open source
20042004-12-31	Operating cash flow	-9006000	Operating Cash Flow: -9006000 Open source
20052005-12-31	Operating cash flow	-17441000	Operating Cash Flow: -17441000 Open source
20062006-12-31	Operating cash flow	-5946000	Operating Cash Flow: -5946000 Open source
20072007-12-31	Operating cash flow	-11137000	Operating Cash Flow: -11137000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -17M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-1112000	Operating Cash Flow: -263000 Open source Capital Expenditure: 849000 Open source
20032003-12-31	Free cash flow	-8943000	Operating Cash Flow: -4780000 Open source Capital Expenditure: 4163000 Open source
20042004-12-31	Free cash flow	-16143000	Operating Cash Flow: -9006000 Open source Capital Expenditure: 7137000 Open source
20052005-12-31	Free cash flow	-18501000	Operating Cash Flow: -17441000 Open source Capital Expenditure: 1060000 Open source
20062006-12-31	Free cash flow	-8622000	Operating Cash Flow: -5946000 Open source Capital Expenditure: 2676000 Open source
20072007-12-31	Free cash flow	-17045000	Operating Cash Flow: -11137000 Open source Capital Expenditure: 5908000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	Total Assets: 11052000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 57005000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 46019000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 66127000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 90398000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.96× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Current assets / current liabilities	Not reported	No source recorded
20032003-12-31	Current assets / current liabilities	0.62×	Current Assets: 3985000 Open source Current Liabilities: 6420000 Open source
20042004-12-31	Current assets / current liabilities	4.2×	Current Assets: 43009000 Open source Current Liabilities: 10251000 Open source
20052005-12-31	Current assets / current liabilities	3.77×	Current Assets: 33393000 Open source Current Liabilities: 8862000 Open source
20062006-12-31	Current assets / current liabilities	2.81×	Current Assets: 52644000 Open source Current Liabilities: 18750000 Open source
20072007-12-31	Current assets / current liabilities	1.96×	Current Assets: 73341000 Open source Current Liabilities: 37471000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 2.14 million Exact value Exact value: -2142000 USD 2002-01-01 – 2002-12-31: -2142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2002-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -2142000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2142000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-05-012531.txt#9838 The citation records this snapshot. The page link may show a newer release later.	−USD 263,000 Exact value Exact value: -263000 USD 2002-01-01 – 2002-12-31: -263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2002-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -263000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -263000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-05-012531.txt#10187 The citation records this snapshot. The page link may show a newer release later.	USD 849,000 Exact value Exact value: 849000 USD 2002-01-01 – 2002-12-31: 849000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2002-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 849000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 849000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-05-012531.txt#10240 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Calculation and evidence -263000 − 849000 USD Exact free cash flow: -1112000 USD 2002-01-01 – 2002-12-31: -263000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 849000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2002-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -1112000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -263000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-05-012531.txt#10187 Input fundies:CapitalExpenditure: 849000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-05-012531.txt#10240 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 2.85 million Exact value Exact value: -2848000 USD 2003-01-01 – 2003-12-31: -2848000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2003-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -2848000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2848000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-06-018053.txt#11401 The citation records this snapshot. The page link may show a newer release later.	−USD 4.78 million Exact value Exact value: -4780000 USD 2003-01-01 – 2003-12-31: -4780000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2003-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -4780000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4780000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-06-018053.txt#11802 The citation records this snapshot. The page link may show a newer release later.	USD 4.16 million Exact value Exact value: 4163000 USD 2003-01-01 – 2003-12-31: 4163000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2003-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 4163000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4163000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-06-018053.txt#11855 The citation records this snapshot. The page link may show a newer release later.	−USD 8.94 million Calculation and evidence -4780000 − 4163000 USD Exact free cash flow: -8943000 USD 2003-01-01 – 2003-12-31: -4780000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 4163000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2003-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -8943000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4780000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-06-018053.txt#11802 Input fundies:CapitalExpenditure: 4163000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-06-018053.txt#11855 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 17.42 million Exact value Exact value: -17420000 USD 2004-01-01 – 2004-12-31: -17420000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2004-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -17420000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17420000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-07-020456.txt#12838 The citation records this snapshot. The page link may show a newer release later.	−USD 9.01 million Exact value Exact value: -9006000 USD 2004-01-01 – 2004-12-31: -9006000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2004-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -9006000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9006000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-07-020456.txt#13265 The citation records this snapshot. The page link may show a newer release later.	USD 7.14 million Exact value Exact value: 7137000 USD 2004-01-01 – 2004-12-31: 7137000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2004-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 7137000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7137000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-07-020456.txt#13318 The citation records this snapshot. The page link may show a newer release later.	−USD 16.14 million Calculation and evidence -9006000 − 7137000 USD Exact free cash flow: -16143000 USD 2004-01-01 – 2004-12-31: -9006000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 7137000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2004-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -16143000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9006000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-07-020456.txt#13265 Input fundies:CapitalExpenditure: 7137000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001104659-07-020456.txt#13318 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 17.14 million Exact value Exact value: -17138000 USD 2005-01-01 – 2005-12-31: -17138000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2005-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -17138000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17138000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#6868 The citation records this snapshot. The page link may show a newer release later.	−USD 17.44 million Exact value Exact value: -17441000 USD 2005-01-01 – 2005-12-31: -17441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2005-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -17441000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17441000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 The citation records this snapshot. The page link may show a newer release later.	USD 1.06 million Exact value Exact value: 1060000 USD 2005-01-01 – 2005-12-31: 1060000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2005-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 1060000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1060000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.	−USD 18.5 million Calculation and evidence -17441000 − 1060000 USD Exact free cash flow: -18501000 USD 2005-01-01 – 2005-12-31: -17441000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 1060000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2005-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -18501000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17441000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 Input fundies:CapitalExpenditure: 1060000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 27.76 million Exact value Exact value: -27764000 USD 2006-01-01 – 2006-12-31: -27764000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2006-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -27764000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27764000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#6868 The citation records this snapshot. The page link may show a newer release later.	−USD 5.95 million Exact value Exact value: -5946000 USD 2006-01-01 – 2006-12-31: -5946000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2006-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -5946000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5946000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 The citation records this snapshot. The page link may show a newer release later.	USD 2.68 million Exact value Exact value: 2676000 USD 2006-01-01 – 2006-12-31: 2676000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2006-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 2676000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2676000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.	−USD 8.62 million Calculation and evidence -5946000 − 2676000 USD Exact free cash flow: -8622000 USD 2006-01-01 – 2006-12-31: -5946000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2676000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2006-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -8622000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5946000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 Input fundies:CapitalExpenditure: 2676000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 47.86 million Exact value Exact value: -47860000 USD 2007-01-01 – 2007-12-31: -47860000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Net Income: -47860000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47860000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#6868 The citation records this snapshot. The page link may show a newer release later.	−USD 11.14 million Exact value Exact value: -11137000 USD 2007-01-01 – 2007-12-31: -11137000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Operating Cash Flow: -11137000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11137000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 The citation records this snapshot. The page link may show a newer release later.	USD 5.91 million Exact value Exact value: 5908000 USD 2007-01-01 – 2007-12-31: 5908000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Capital Expenditure: 5908000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5908000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.	−USD 17.05 million Calculation and evidence -11137000 − 5908000 USD Exact free cash flow: -17045000 USD 2007-01-01 – 2007-12-31: -11137000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 5908000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMACOPEIA INC · 2007-12-31 PHARMACOPEIA INC (edgar:1273013) Free cash flow: -17045000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T16:29:18Z Snapshot: 39d0954554e095aafc5a47013550e0908c9e78ef1bc27898774ce9efd273e470 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1273013?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11137000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7123 Input fundies:CapitalExpenditure: 5908000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1273013/0001047469-08-002307.txt#7153 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

21 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001273013, 1273013, edgar:1273013

Also known as PHARMACOPEIA DRUG DISCOVERY INC

PHARMACOPEIA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation